Localized Kidney Cancer
Urologists attending this year’s meeting will find localized kidney cancer content covering a wide variety of subjects.
“Urologists continue to explore various techniques for nephron-sparing surgery for renal cancer. There is increasing interest in the role of tumor enucleation, and in fact this is one of the topics in the Crossfire debate series on Friday,” said J. Stuart Wolf, Jr., MD, professor of urology at the University of Michigan, Ann Arbor.
Dr. Wolf also said AUA studies will examine surgery-related trends involving bleeding complications and ablation versus excision.
“With the growing awareness that discontinuation of anti-platelet therapy puts some patients at significant cardiac risk, more renal surgery is being performed without discontinuation of anti-platelet therapy. We are learning more about the impact of that practice on bleeding complications associated with renal surgery,” he said.
Finally, “There still is no clarity as to the role of thermal ablation versus excision for the management of small renal cancers, although evidence continues to be developed.”
Here are Dr. Wolf's abstract picks on localized kidney cancer:
MP41-10: Renal Tumor Enucleation Maximally Preserves Renal Parenchymal Volume Compared to Standard Partial Nephrectomy
Robert H. Blackwell
MP41-18: PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY
MP64-05: Surgical Salvage of Thermal Ablation Failures for Renal Cell Carcinoma
PD41-08: Patients Who Maintain Normal Glomerular Filtration Rate (GFR) Despite Coronary Artery Disease Appear Resistant to Marked GFR Decline Following Radical Nephrectomy
MP75-08: Could perirenal fat be more important than the tumor itself? The MAP score better predicts perioperative morbidity than the RENAL score.
PD48-10: Examination of perioperative outcomes following partial nephrectomy performed on patients remaining on antiplatelet therapy